# PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia

> **NCT00549341** · PHASE1 · COMPLETED · sponsor: **Mentor Worldwide, LLC** · enrollment: 70 (actual)

## Conditions studied

- Spasmodic Torticollis

## Interventions

- **DRUG:** Mentor Purified Toxin, Botulinum Toxn Type A, Purified Neurotoxin
- **OTHER:** Physiologic saline

## Key facts

- **NCT ID:** NCT00549341
- **Lead sponsor:** Mentor Worldwide, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-09
- **Final completion:** 2009-03
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00549341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00549341, "PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00549341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*